Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen

References

• Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., & Zwart, P. H. (2010). PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 2), 213–221. https://doi.org/10.1107/S0907444909052925
   PubMed Web of Science ®Google Scholar
• Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009). Knockout mice in understanding the mechanism of action of lithium. Biochemical Society Transactions, 37(Pt 5), 1121–1125. https://doi.org/10.1042/BST0371121
   PubMedGoogle Scholar
• Amporndanai, K., Meng, X., Shang, W., Jin, Z., Rogers, M., Zhao, Y., Rao, Z., Liu, Z.-J., Yang, H., Zhang, L., O'Neill, P. M., & Samar Hasnain, S. (2021). Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nature Communications, 12(1), 3061. https://doi.org/10.1038/s41467-021-23313-7
   PubMed Web of Science ®Google Scholar
• Atack, J. R. (1995). Inositol monophosphatase inhibitors: A novel treatment for bipolar disorder? Biological Psychiatry, 37(11), 761–763. https://doi.org/10.1016/0006-3223(95)00020-H
   PubMed Web of Science ®Google Scholar
• Atack, J. R. (1997). Inositol monophosphatase inhibitors–lithium mimetics? Medicinal Research Reviews, 17(2), 215–224. https://doi.org/10.1002/(sici)1098-1128(199703)17:2 < 215::aid-med3 > 3.0.co;2-2
   PubMed Web of Science ®Google Scholar
• Atack, J. R., Broughton, H. B., & Pollack, S. J. (1995). Inositol monophosphatase–a putative target for Li + in the treatment of bipolar disorder. Trends in Neurosciences, 18(8), 343–349. https://doi.org/10.1016/0166-2236(95)93926-o
   PubMed Web of Science ®Google Scholar
• Belmaker, R. H., Bersudsky, Y., Agam, G., Levine, J., & Kofman, O. (1996). How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annual Review of Medicine, 47(1), 47–56. https://doi.org/10.1146/annurev.med.47.1.47
   PubMed Web of Science ®Google Scholar
• Berridge, M. J., & Irvine, R. F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312(5992), 315–321. https://doi.org/10.1038/312315a0
   PubMed Web of Science ®Google Scholar
• Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989). Neural and developmental actions of lithium: A unifying hypothesis. Cell, 59(3), 411–419. https://doi.org/10.1016/0092-8674(89)90026-3
   PubMed Web of Science ®Google Scholar
• BIOVIA. (2019). Dassault Systèmes, BIOVIA Discovery Studio Visualizer, v19.1.0.18287. San Diego: Dassault Systèmes.
   Google Scholar
• Bone, R., Frank, L., Springer, J. P., & Atack, J. R. (1994). Structural studies of metal binding by inositol monophosphatase: Evidence for two-metal ion catalysis. Biochemistry, 33(32), 9468–9476. https://doi.org/10.1021/bi00198a012
   PubMed Web of Science ®Google Scholar
• Bone, R., Frank, L., Springer, J. P., Pollack, S. J., Osborne, S. A., Atack, J. R., Knowles, M. R., McAllister, G., Ragan, C. I., & Broughton, H. B. (1994). Structural analysis of inositol monophosphatase complexes with substrates. Biochemistry, 33(32), 9460–9467. https://doi.org/10.1021/bi00198a011
   PubMed Web of Science ®Google Scholar
• Chiou, J., Wan, S., Chan, K.-F., So, P.-K., He, D., Chan, E. W-c., Chan, T-h., Wong, K-y., Tao, J., & Chen, S. (2015). Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1). Chemical Communications (Cambridge, England), 51(46), 9543–9546.
   PubMed Web of Science ®Google Scholar
• Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., & Richardson, D. C. (2007). MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research, 35(Web Server issue), W375–383. https://doi.org/10.1093/nar/gkm216
   PubMedGoogle Scholar
• de Munnik, M., Lohans, C. T., Lang, P. A., Langley, G. W., Malla, T. R., Tumber, A., Schofield, C. J., & Brem, J. (2019). Targeting the Mycobacterium tuberculosis transpeptidase Ldt Mt2 with cysteine-reactive inhibitors including ebselen. Chemical Communications (Cambridge, England), 55(69), 10214–10217.
   PubMed Web of Science ®Google Scholar
• Demissie, M., Hanlon, C., Birhane, R., Ng, L., Medhin, G., & Fekadu, A. (2018). Psychological interventions for bipolar disorder in low- and middle-income countries: Systematic review. BJPsych Open, 4(5), 375–384. https://doi.org/10.1192/bjo.2018.46
   PubMed Web of Science ®Google Scholar
• Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010). Features and development of Coot. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 4), 486–501. https://doi.org/10.1107/S0907444910007493
   PubMed Web of Science ®Google Scholar
• Evans, P. (2006). Scaling and assessment of data quality. Acta Crystallographica. Section D, Biological Crystallography, 62(Pt 1), 72–82. https://doi.org/10.1107/S0907444905036693
   PubMedGoogle Scholar
• Favrot, L., Grzegorzewicz, A. E., Lajiness, D. H., Marvin, R. K., Boucau, J., Isailovic, D., Jackson, M., & Ronning, D. R. (2013). Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen. Nature Communications, 4(1), 2748. https://doi.org/10.1038/ncomms3748
   PubMedGoogle Scholar
• Fenn, G. D., Waller-Evans, H., Atack, J. R., & Bax, B. D. (2020). Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase. Acta Crystallographica. Section F, Structural Biology Communications, 76(Pt 10), 469–476. https://doi.org/10.1107/S2053230X20011310
   PubMedGoogle Scholar
• Ferrari, A. J., Stockings, E., Khoo, J.-P., Erskine, H. E., Degenhardt, L., Vos, T., & Whiteford, H. A. (2016). The prevalence and burden of bipolar disorder: Findings from the Global Burden of Disease Study 2013. Bipolar Disorders, 18(5), 440–450. https://doi.org/10.1111/bdi.12423
   PubMed Web of Science ®Google Scholar
• Ganzhorn, A. J., Lepage, P., Pelton, P. D., Strasser, F., Vincendon, P., & Rondeau, J. M. (1996). The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Biochemistry, 35(33), 10957–10966. https://doi.org/10.1021/bi9603837
   PubMed Web of Science ®Google Scholar
• Ganzhorn, A., & Rondean, J. (1997). Structure of an enzyme-substrate complex and the catalytic mechanism of human brain myo-inositol monophosphatase. Protein Engineering, 10, 61–61.
   Google Scholar
• Gee, N. S., Ragan, C. I., Watling, K. J., Aspley, S., Jackson, R. G., Reid, G. G., Gani, D., & Shute, J. K. (1988). The purification and properties of myo-inositol monophosphatase from bovine brain. The Biochemical Journal, 249(3), 883–889. https://doi.org/10.1042/bj2490883
   PubMed Web of Science ®Google Scholar
• Gill, R., Mohammed, F., Badyal, R., Coates, L., Erskine, P., Thompson, D., Cooper, J., Gore, M., & Wood, S. (2005). High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy. Acta Crystallographica. Section D, Biological Crystallography, 61(Pt 5), 545–555. https://doi.org/10.1107/S0907444905004038
   PubMedGoogle Scholar
• Gore, M., Greasley, P., McAllister, G., & Ragan, C. (1993). Mammalian inositol monophosphatase: The identification of residues important for the binding of Mg2+ and Li + ions using fluorescence spectroscopy and site-directed mutagenesis. Biochemical Journal, 296(3), 811–815.
   PubMedGoogle Scholar
• Greasley, P. J., & Gore, M. G. (1993). Bovine inositol monophosphatase. Studies on the binding interactions with magnesium, lithium and phosphate ions. FEBS Letters, 331(1-2), 114–118. https://doi.org/10.1016/0014-5793(93)80308-h
   PubMed Web of Science ®Google Scholar
• Greasley, P. J., Hunt, L. G., & Gore, M. G. (1994). Bovine inositol monophosphatase. Ligand binding to pyrene-maleimide-labelled enzyme. European Journal of Biochemistry, 222(2), 453–460. https://doi.org/10.1111/j.1432-1033.1994.tb18885.x
   PubMedGoogle Scholar
• Hallcher, L. M., & Sherman, W. R. (1980). The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry, 255(22), 10896–10901.
   PubMed Web of Science ®Google Scholar
• Herschlag, D., & Jencks, W. P. (1990). Catalysis of the hydrolysis of phosphorylated pyridines by Mg (OH)+: A possible model for enzymic phosphoryl transfer. Biochemistry, 29(21), 5172–5179.
   PubMed Web of Science ®Google Scholar
• Jackson, R. G., Gee, N. S., & Ragan, C. I. (1989). Modification of myo-inositol monophosphatase by the arginine-specific reagent phenylglyoxal. The Biochemical Journal, 264(2), 419–422. https://doi.org/10.1042/bj2640419
   PubMed Web of Science ®Google Scholar
• Jacob, C., Maret, W., & Vallee, B. L. (1998). Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Biochemical and Biophysical Research Communications, 248(3), 569–573. https://doi.org/10.1006/bbrc.1998.9026
   PubMed Web of Science ®Google Scholar
• Kabsch, W. (2010). XDS. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 2), 125–132. https://doi.org/10.1107/S0907444909047337
   PubMedGoogle Scholar
• Knowles, M. R. (1992). Bovine inositol monophosphatase. Modification, identification and mutagenesis of reactive cysteine residues. The Biochemical Journal, 285(Pt 2), 461–468. https://doi.org/10.1042/bj2850461
   PubMedGoogle Scholar
• Kraft, L., Roe, S. M., Gill, R., & Atack, J. R. (2018). Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallographica. Section D, Structural Biology, 74(Pt 10), 973–978. https://doi.org/10.1107/S2059798318010380
   PubMedGoogle Scholar
• Kraft, L., Roe, S. M., Gill, R., & Atack, J. R. (2018). Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallographica Section D, 74(10), 973–978. https://doi.org/10.1107/S2059798318010380
   Google Scholar
• Lu, S., Huang, W., Li, X., Huang, Z., Liu, X., Chen, Y., Shi, T., & Zhang, J. (2012). Insights into the role of magnesium triad in myo-inositol monophosphatase: Metal mechanism, substrate binding, and lithium therapy. Journal of Chemical Information and Modeling, 52(9), 2398–2409. https://doi.org/10.1021/ci300172r
   PubMed Web of Science ®Google Scholar
• Martini, F., Bruning, C. A., Soares, S. M., Nogueira, C. W., & Zeni, G. (2015). Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: Kinetics and reversibility of inhibition. Current Pharmaceutical Design, 21(7), 920–924. https://doi.org/10.2174/1381612820666141014124319
   PubMed Web of Science ®Google Scholar
• McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007). Phaser crystallographic software. Journal of Applied Crystallography, 40(Pt 4), 658–674. https://doi.org/10.1107/S0021889807021206
   PubMed Web of Science ®Google Scholar
• McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012). Lithium toxicity profile: A systematic review and meta-analysis. Lancet (London, England), 379(9817), 721–728. https://doi.org/10.1016/S0140-6736(11)61516-X
   PubMed Web of Science ®Google Scholar
• Menendez, C. A., Bylehn, F., Perez-Lemus, G. R., Alvarado, W., & de Pablo, J. J. (2020). Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease. Science Advances 6(37), eabd0345. https://doi.org/10.1126/sciadv.abd0345
   PubMed Web of Science ®Google Scholar
• Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallographica. Section D, Biological Crystallography, 53(Pt 3), 240–255. https://doi.org/10.1107/S0907444996012255
   PubMedGoogle Scholar
• Niesen, F. H., Berglund, H., & Vedadi, M. (2007). The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nature Protocols, 2(9), 2212–2221. https://doi.org/10.1038/nprot.2007.321
   PubMed Web of Science ®Google Scholar
• O'Leary, V., & Solberg, M. (1976). Effect of sodium nitrite inhibition on intracellular thiol groups and on the activity of certain glycolytic enzymes in Clostridium perfringens. Applied and Environmental Microbiology, 31(2), 208–212. https://doi.org/10.1128/aem.31.2.208-212.1976
   PubMed Web of Science ®Google Scholar
• Patel, S., Martınez-Ripoll, M., Blundell, T. L., & Albert, A. (2002). Structural enzymology of Li+-sensitive/Mg2+-dependent phosphatases. Journal of Molecular Biology, 320(5), 1087–1094.
   PubMed Web of Science ®Google Scholar
• Pelton, P. D., & Ganzhorn, A. J. (1992). The effect of histidine modification on the activity of myo-inositol monophosphatase from bovine brain. Journal of Biological Chemistry, 267(9), 5916–5920.
   PubMed Web of Science ®Google Scholar
• Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., Reilly-Harrington, N. A., Nierenberg, A. A., Sachs, G. S., & Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry, 163(2), 217–224. https://doi.org/10.1176/appi.ajp.163.2.217
   PubMed Web of Science ®Google Scholar
• Petra, P. H., Cohen, W., & Shaw, E. N. (1965). Isolation and characterization of the alkylated histidine from TLCK inhibited trypsin. Biochemical and Biophysical Research Communications, 21(6), 612–618. https://doi.org/10.1016/0006-291x(65)90530-9
   PubMed Web of Science ®Google Scholar
• Pollack, S. J., Knowles, M. R., Atack, J. R., Broughton, H. B., Ragan, C. I., Osborne, S., & McAllister, G. (1993). Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis. European Journal of Biochemistry, 217(1), 281–287. https://doi.org/10.1111/j.1432-1033.1993.tb18244.x
   PubMedGoogle Scholar
• Rees-Milton, K. J., Greasley, P. J., Ragan, C. I., & Gore, M. G. (1993). Bovine inositol monophosphatase. FEBS Letters, 321(1), 37–40. https://doi.org/10.1016/0014-5793(93)80616-3
   PubMed Web of Science ®Google Scholar
• Rose, N. R., Thalhammer, A., Seden, P. T., Mecinović, J., & Schofield, C. J. (2009). Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn (II). Chemical Communications, 42, 6376–6378.
   Google Scholar
• Rydzik, A. M., Brem, J., Struwe, W. B., Kochan, G. T., Benesch, J. L. P., & Schofield, C. J. (2014). Ejection of structural zinc leads to inhibition of gamma-butyrobetaine hydroxylase. Bioorganic & Medicinal Chemistry Letters, 24(21), 4954–4957. https://doi.org/10.1016/j.bmcl.2014.09.035
   PubMed Web of Science ®Google Scholar
• Schwarz, J. (2016). Atypical elements in drug design. Springer.
   Google Scholar
• Sies, H. (1995). Methods in enzymology (Vol. 252, pp. 341–342). Elsevier.
   Google Scholar
• Singh, N., Halliday, A. C., Knight, M., Lack, N. A., Lowe, E., & Churchill, G. C. (2012). Cloning, expression, purification, crystallization and X-ray analysis of inositol monophosphatase from Mus musculus and Homo sapiens. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 68(Pt 10), 1149–1152. https://doi.org/10.1107/S1744309112035191
   PubMedGoogle Scholar
• Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O. V., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I., Sharp, T., Vasudevan, S. R., & Churchill, G. C. (2013). A safe lithium mimetic for bipolar disorder. Nature Communications, 4(1), 1332. https://doi.org/10.1038/ncomms2320
   PubMedGoogle Scholar
• Singh, N., Sharpley, A. L., Emir, U. E., Masaki, C., Herzallah, M. M., Gluck, M. A., Sharp, T., Harmer, C. J., Vasudevan, S. R., Cowen, P. J., & Churchill, G. C. (2016). Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 41(7), 1768–1778. https://doi.org/10.1038/npp.2015.343
   PubMed Web of Science ®Google Scholar
• Thorne, M. R., Greasley, P. J., & Gore, M. G. (1996). Bovine inositol monophosphatase: Enzyme-metal-ion interactions studied by pre-equilibrium fluorescence spectroscopy. The Biochemical Journal, 315(Pt 3), 989–994. https://doi.org/10.1042/bj3150989
   PubMedGoogle Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., Hui, R., Marsden, B. D., Nordlund, P., Sundstrom, M., Weigelt, J., & Edwards, A. M. (2006). Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proceedings of the National Academy of Sciences of the United States of America, 103(43), 15835–15840. https://doi.org/10.1073/pnas.0605224103
   PubMed Web of Science ®Google Scholar
• Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews. Disease Primers, 8(4), 18008. https://doi.org/10.1038/nrdp.2018.8
   Google Scholar
• Wagner, G., Schuch, G., Akerboom, T. P., & Sies, H. (1994). Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochemical Pharmacology, 48(6), 1137–1144. https://doi.org/10.1016/0006-2952(94)90150-3
   PubMed Web of Science ®Google Scholar
• Waldron, T. T., & Murphy, K. P. (2003). Stabilization of proteins by ligand binding:  Application to drug screening and determination of unfolding energetics. Biochemistry, 42(17), 5058–5064. https://doi.org/10.1021/bi034212v
   PubMed Web of Science ®Google Scholar
• Walther, M., Holzhütter, H. G., Kuban, R. J., Wiesner, R., Rathmann, J., & Kühn, H. (1999). The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: Dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Molecular Pharmacology, 56(1), 196–203. https://doi.org/10.1124/mol.56.1.196
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, P., Dong, C., Zhao, Y., Zhou, J., Yuan, C., & Zou, L. (2020). Mechanisms of ebselen as a therapeutic and its pharmacology applications. Future Medicinal Chemistry, 12(23), 2141–2160.
   PubMed Web of Science ®Google Scholar
• Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., & Wilson, K. S. (2011). Overview of the CCP4 suite and current developments. Acta Crystallographica. Section D, Biological Crystallography, 67(Pt 4), 235–242. https://doi.org/10.1107/S0907444910045749
   PubMedGoogle Scholar
• Yalçın, G., & Yılmaz, Ş. (2004). Determination of ebselen by HPLC: Validation and application of the method. Chromatographia, 60, 583–587.
   Web of Science ®Google Scholar